Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Oligonucleotide-induced alternative splicing of serotonin 2C receptor reduces food intake

Producción científica: Article › revisión exhaustiva

27 Citas (Scopus)

Resumen

The serotonin 2C receptor regulates food uptake, and its activity is regulated by alternative pre-mRNA splicing. Alternative exon skipping is predicted to generate a truncated receptor protein isoform, whose existence was confirmed with a new antiserum. The truncated receptor sequesters the full-length receptor in intracellular membranes. We developed an oligonucleotide that promotes exon inclusion, which increases the ratio of the full-length to truncated receptor protein. Decreasing the amount of truncated receptor results in the accumulation of full-length, constitutively active receptor at the cell surface. After injection into the third ventricle of mice, the oligonucleotide accumulates in the arcuate nucleus, where it changes alternative splicing of the serotonin 2C receptor and increases pro-opiomelanocortin expression. Oligonucleotide injection reduced food intake in both wild-type and ob/ob mice. Unexpectedly, the oligonucleotide crossed the blood–brain barrier and its systemic delivery reduced food intake in wild-type mice. The physiological effect of the oligonucleotide suggests that a truncated splice variant regulates the activity of the serotonin 2C receptor, indicating that therapies aimed to change pre-mRNA processing could be useful to treat hyperphagia, characteristic for disorders like Prader–Willi syndrome.

Idioma originalEnglish
Páginas (desde-hasta)878-894
Número de páginas17
PublicaciónEMBO Molecular Medicine
Volumen8
N.º8
DOI
EstadoPublished - ago 1 2016

Nota bibliográfica

Publisher Copyright:
© 2016 The Authors. Published under the terms of the CC BY 4.0 license

Financiación

We are very grateful to the NIMH/Vanderbilt Silvio O. Conte Center for support of these studies (P50 MH096972). This work also was supported by National Institutes of Health RO1 GM083187, R21HD080035, and P20RR020171 to S. S and the Foundation for Prader–Willi Research, and by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (8 P20 GM103527-06).

FinanciadoresNúmero del financiador
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Foundation for Prader Willi Research
National Institutes of Health (NIH)
National Institute of General Medical Sciences DP2GM119177 Sophie Dumont National Institute of General Medical SciencesR01GM083187, P20GM103527
NIH National Institute of Child Health and Human Development National Center for Medical Rehabilitation ResearchR21HD080035, U54HD083211
Vanderbilt Digestive Diseases Research Center, Vanderbilt University Medical CenterP50 MH096972
National Institute of Mental HealthP50MH096972
Institute of Neurological Disorders and Stroke National Advisory Neurological Disorders and Stroke CouncilR21NS098186
National Center for Research ResourcesP20RR020171

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Molecular Medicine

    Huella

    Profundice en los temas de investigación de 'Oligonucleotide-induced alternative splicing of serotonin 2C receptor reduces food intake'. En conjunto forman una huella única.

    Citar esto